ArticleFrontiers in endocrinology2026
The association of beliefs about medicines with medication adherence and glycemic control among patients with type 2 diabetes: a cross-sectional survey.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Beliefs about medicines have been identified as important determinants of medication adherence for multiple chronic diseases such as hypertension, diabetes, and asthma. This study aimed to examine the association of beliefs about medicines with medication adherence and glycemic control among patients with type 2 diabetes (T2D) in Xi'an, China. Methods: A cross-sectional study was conducted with T2D patients recruited from two large tertiary hospitals in Xi'an, China, from August 1, 2024 to March 31, 2025. The Beliefs about Medicines Questionnaire (BMQ) was used to assess patients' beliefs about hypoglycemic agents, and the Adherence to Refills and Medications Scale in Diabetes (ARMS-D) was used to assess adherence to hypoglycemic agents. The recommended cut-off of HbA1c<7.0% was used as an indicator of glycemic control. Logistic regression analyses were performed to investigate the determinants of both medication adherence and glycemic control. Receiver operating characteristic (ROC) analyses were conducted to assess the performance of the logistic regression model in predicting adherence to hypoglycemic agents. Results: Of these 446 patients enrolled in the study, the overall medication adherence was 32.5%, while 30.5% of patients achieved adequate glycemic control (HbA1c <7.0%). Multivariable logistic regression analyses revealed that patients who expressed stronger concern beliefs about the medicine had 1.20 (95% CI = 1.130-1.264) and 1.08 (95% CI = 1.022-1.136) times greater odds of non-adherence to hypoglycemic agents and inadequate glycemic control, respectively, than those expressed weaker concern beliefs, while necessity beliefs about the medicine were significantly negatively associated with medication non-adherence (adjusted OR 0.873 [0.814, 0.936]; p<0.001) and inadequate glycemic control (adjusted OR 0.916 [0.853, 0.983]; p = 0.015). This study found that presence of comorbidities and longer duration of diabetes (>10 years) was associated with medication adherence. Diabetes duration for 5-10 years and higher income were found to be associated with glycemic control, while taking injectable hypoglycemic agents and alcohol consumption were associated with inadequate glycemic control among T2D patients. Conclusion: This study revealed the status of suboptimal glycemic control and medication adherence of patients with T2D in Xi'an. Pharmacists and nurses could play an important role in educational and behavioral intervention of patients' beliefs about medicines.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.